World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
22451
World Ranking
19080
National Ranking
611

Masafumi Taniwaki publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Masafumi Taniwaki sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 638 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Masafumi Taniwaki D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Masafumi Taniwaki sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Best Publications

  • CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

    Yoshiya Kawaguchi;Toshihiro Okamoto;Masafumi Taniwaki;Megumi Aizawa

  • Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    Abstr Act;Sagar Lonial;Meletios Dimopoulos;Antonio Palumbo

  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    Steven Horwitz;Owen A O'Connor;Barbara Pro;Tim Illidge

  • A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue.

    Tomoaki Akagi;Mutsuhito Motegi;Akiko Tamura;Ritsuro Suzuki

  • Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.

    Michinori Ogura;Takashi Ishida;Kiyohiko Hatake;Masafumi Taniwaki

  • Structure and chromosomal localization of the human PD-1 gene (PDCD1)

    Takashi Shinohara;Masafumi Taniwaki;Yasumasa Ishida;Masashi Kawaichi

  • Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13).

    Kohmei Ida;Issay Kitabayashi;Tomohiko Taki;Masafumi Taniwaki

  • Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage

    Kiyomitsu Arai;Kiyomitsu Arai;Kazuhiro Morishita;Kazuya Shinmura;Takashi Kohno

  • Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

    Shigeki Ohtake;Shuichi Miyawaki;Hiroyuki Fujita;Hitoshi Kiyoi

  • Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia

    S Horiike;S Yokota;M Nakao;T Iwai

  • IRTA1 and IRTA2, Novel Immunoglobulin Superfamily Receptors Expressed in B Cells and Involved in Chromosome 1q21 Abnormalities in B Cell Malignancy

    Georgia Hatzivassiliou;Ira Miller;Jun Takizawa;Nallasivam Palanisamy

  • Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults

    Takahiko Yasuda;Takahiko Yasuda;Shinobu Tsuzuki;Masahito Kawazu;Fumihiko Hayakawa

  • The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization

    Kazuhiro Nishida;Akiko Tamura;Akiko Tamura;Naozo Nakazawa;Naozo Nakazawa;Yutaka Ueda;Yutaka Ueda

  • Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.

    Maria-Victoria Mateos;Hilary Blacklock;Fredrik Schjesvold;Albert Oriol

  • DANCE, a Novel Secreted RGD Protein Expressed in Developing, Atherosclerotic, and Balloon-injured Arteries

    Tomoyuki Nakamura;Pilar Ruiz-Lozano;Volkhard Lindner;Daisuke Yabe

  • Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene.

    Taro Muto;Masamichi Muramatsu;Masafumi Taniwaki;Kazuo Kinoshita

  • A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study.

    Shuichi Miyawaki;Shigeki Ohtake;Shin Fujisawa;Hitoshi Kiyoi

  • Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis

    Shigeo Horiike;Masafumi Taniwaki;Shinichi Misawa;Tatsuo Abe

  • Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

    T. Igarashi;Y. Kobayashi;M. Ogura;T. Kinoshita

  • AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)

    Tomohiko Taki;Hirotsugu Kano;Masafumi Taniwaki;Masahiro Sako

Frequent Co-Authors

Tomohiko Taki
Tomohiko Taki Kyorin University
Tatsuo Abe
Tatsuo Abe Kyoto Prefectural University of Medicine
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Johji Inazawa
Johji Inazawa Tokyo Medical and Dental University
Tomoki Naoe
Tomoki Naoe Nagoya University
Yasuo Morishima
Yasuo Morishima Aichi Medical University
Eishi Ashihara
Eishi Ashihara Kyoto Pharmaceutical University
Naokuni Uike
Naokuni Uike National Hospital Organization Kyushu Cancer Center
Toshikazu Yoshikawa
Toshikazu Yoshikawa Kyoto Prefectural University of Medicine
Yasuhide Hayashi
Yasuhide Hayashi Gunma Children's Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of Medicine in the USA opens up diverse opportunities beyond becoming a physician. For those seeking flexible education or alternative entry points, online programs offer convenient pathways to rewarding careers in healthcare.

One popular route is through medical coding and billing classes online with financial aid, which prepare students for essential administrative roles while minimizing financial burden. If patient care is your passion, consider nursing schools that don't require teas or hesi, removing common testing barriers and simplifying the admissions process.

For future leaders aiming to influence the healthcare system, a health care administration degree online can provide management expertise on a fast track. Registered nurses ready to advance may benefit from structured rn to np bridge program options, enabling a smooth transition to advanced practice roles.

Each of these online pathways supports your career ambitions in the medical field, offering flexibility and accessible routes to specialized roles within healthcare.

Best Scientists Citing Masafumi Taniwaki

Trending Scientists

Recently Published Articles